Project Grant HT94252510072
Award Date
9/1/25
Completion Date
8/31/29
Dollars Obligated
$1.5M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Houston, TX 77030, USA
Similar Awards
This $1,200,000 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research by Baylor College of Medicine to eliminate bone metastasis through a bone-targeting E-cadherin antibody nanogel. The 4-year award, effective from April 1, 2025 to March 31, 2028, aims to transform healthcare for military service members, veterans, and the broader public through innovative biomedical research. As a leading academic medical...
The federal Project Grant award of $1,597,224.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program to support the research project "BCL-XL IN BREAST CANCER METASTASIS AND THERAPY" at Baylor College of Medicine in Houston, Texas. The award, with a performance period from August 1, 2024 to July 31, 2027, will fund advanced biomedical research initiatives focused on transforming healthcare for military service...
This $1,599,997.00 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at the University of Illinois aimed at transforming healthcare for military service members, veterans, and the broader public. The research, spanning basic, applied, and translational investigations, focuses on innovative approaches to address critical health challenges across diverse medical domains such as cancer,...
The federal Project Grant award of $1,008,313 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. This award supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The award was granted to The Regents of the University of California, San Francisco (UCSF), a prominent academic medical center and research institution, to conduct research on melanoma....
This $1,200,000.00 Project Grant was awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award will fund Baylor College of Medicine to conduct research on precision glycocalyx editing of the metastatic bone microenvironment over a three-year period from September 15, 2023 to September 14, 2026. As a private non-profit university, Baylor College of Medicine has extensive experience managing federal grants and contracts for biomedical...
The U.S. Defense Health Agency awarded Baylor College of Medicine a $896,645.00 Project Grant on May 15, 2024 under the Military Medical Research and Development program (CFDA 12.420). This grant supports research to investigate thromboinflammation in rheumatoid arthritis, with a performance period from May 2024 to May 2028. As part of this project, Baylor College of Medicine has provided $28,061 in sub-grant funding to the University of Houston System to construct and characterize wild-type and...
The federal Project Grant award, with ID HT94252410992, was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award, totaling $2,710,479.00, will fund a research initiative led by the University of Texas M.D. Anderson Cancer Center to advance the understanding of metastatic breast cancer through the development of a comprehensive research platform. The award's performance period is from August 15, 2024 to...
This $1,600,000.00 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports research at Baylor College of Medicine focused on developing new synthetic lethal combination therapies targeting TopBP1 and the arachidonic acid pathway for breast cancer treatment. The three-year award, with an end date of February 28, 2027, will fund basic, translational, and clinical research aimed at advancing scientific understanding and...
This federal Project Grant award, valued at $363,160.00, was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). The grant funds the University of Texas Southwestern Medical Center, also known as Southwestern Medical School, to conduct research on the development of bioresorbable heart valves. This advanced biomedical research aims to transform healthcare for military service members, veterans, and the broader public by...
This $1,543,430 federal Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research to target thromboinflammation in rheumatoid arthritis. The award was made to Baylor College of Medicine, a leading academic medical center in Houston, Texas, on May 15, 2024, with a period of performance through May 14, 2028. The grant enables Baylor to conduct innovative biomedical research focused on improving health outcomes...